The inoculation, called V920, was developed by Merck.
- By Helen Branswell, STAT on May 14, 2018
Read more
Experimental Vaccine Will be Used against Ebola Outbreak in the DRC
Posted in biotech/medical
Posted in biotech/medical
The inoculation, called V920, was developed by Merck.